Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

LeMaitre Vascular Sees Q2 EPS $0.45-$0.50 vs $0.44 Est., Sales $53.7M-$56.1M vs $54.29M Est.; Sees FY24 EPS $1.73-$1.84 vs $1.65 Est., Sales $212.7M-$217.3M vs $211.7M Est.

Author: Benzinga Newsdesk | May 02, 2024 05:42pm

Posted In: LMAT